News Features Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile Michael O'Riordan October 17, 2025
News Conference News ESC 2025 PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy Michael O'Riordan September 01, 2025
News Conference News ESC 2025 MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide Caitlin E. Cox August 30, 2025
News Daily News Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More Michael O'Riordan December 06, 2024
News Conference News HFSA 2024 ‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM L.A. McKeown October 02, 2024
News Conference News HRS 2024 Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus Michael O'Riordan May 23, 2024
News Conference News ESC 2023 ESC Cardiomyopathy Guidelines Span Range of Phenotypes Yael L. Maxwell August 31, 2023
News Conference News ESC Heart Failure 2023 Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues Shelley Wood May 25, 2023
News Features Heart Failure Care Has a Pipeline Problem: What’s the Fix? Shelley Wood December 20, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis Yael L. Maxwell February 24, 2022
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021
News Daily News Microvascular Thrombi Common in Patients Dying of COVID-19 Michael O'Riordan January 27, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Features Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era Todd Neale November 02, 2020
News Conference News ESC 2020 EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class Michael O'Riordan August 29, 2020